Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Brexit, Coronavirus, AstraZeneca

Sun, 13th Dec 2020 18:57

(Sharecast News) - Britain and the EU have taken a step forward towards striking a post-Brexit trade and security deal after Boris Johnson and Ursula von der Leyen agreed to "go the extra mile" and ordered the resumption of talks in Brussels. The prime minister played down expectations following the telephone conversation with the European commission president, telling the cabinet to prepare for a no-deal exit when the transition period ends in three weeks' time. But in Brussels, EU embassies were briefed by the commission that "progress has been made" and that "the next days will be important". - Guardian

Britain could be "back to normal" by summer as long as it avoids a third wave after Christmas, the British scientist behind a Covid vaccine has said. Professor Sarah Gilbert, the lead researcher on the Oxford vaccine, said "people's behaviour in the coming weeks is going to have a big impact" on when facemasks and social distancing requirements can be dropped. She said that a spike in coronavirus cases in January would disrupt vaccination programmes. - Sunday Times

Britain's biggest maker of pharmaceuticals has swooped on an American rival in a daring move on the eve of Brexit. Astra Zeneca, the FTSE 100 drug-maker playing a central role in the fight against Covid-19, has agreed to buy Alexion Pharmaceuticals for $39bn (£28.9bn). The cash-and-shares deal will cement the Anglo-Swedish giant's position in immunology and give it a dedicated rare disease business based in Boston, Massachusetts. - Sunday Times

Keith Williams is a man of many modes of transport. The corporate veteran spent 18 years at airline British Airways - the final five as chief executive and chairman - and will in the New Year publish his long-awaited review into the rail industry. Now he is the boss of Royal Mail - and drones are firmly on his radar. Williams wants to use the unmanned vehicles to fly letters to remote areas in the UK. 'If you take, say, the Scilly Isles - an expensive piece of water [to cross] - they might be ideally suited to a drone,' he says. - Mail on Sunday

More Leave voters than Remainers have swung from the Tories to Labour since the last election, according to a major polling project that suggests Keir Starmer, the Labour leader, has made some early progress in bridging the Brexit divide. A large 7,000-strong poll, designed to examine the political changes that have taken place since Labour's disastrous result, found that the party was showing signs of winning over some of those who backed the Tories last year. - Guardian

Giant American fashion and investment corporations are eyeing up bids for Topshop and its parent group Arcadia. [...] Around 30 to 40 potential buyers are believed to have shown initial interest and have received a limited information pack on the business from Arcadia's administrators, Deloitte. First-round bids are due in by the end of this week. - Mail on Sunday

A French satellite giant is muscling in on Britain's broadband market by targeting half a million people in the remotest parts of the nation. Eutelsat has launched Konnect, a satellite broadband service for homes that will not benefit from industry efforts to carpet Britain in gigabit speed connectivity. The service was rolled-out in the UK last week ahead of expanding across Europe and parts of Africa using the same satellite infrastructure. - Sunday Telegraph

Mike Ashley is racing to complete a deal to buy Debenhams this weekend, sources have told The Mail on Sunday. The sportswear mogul is in talks to buy the £500million web business - to help him crack the high-end cosmetics market - but the Debenhams store chain has been vastly slimmed down. 'There's very little time left to rescue the business,' said one City source. 'But without at least 30 or 40 of the 124Nightcap stores, this might not look very much like a rescue at all.' - Mail on Sunday

Dragons' Den entrepreneur Sarah Willingham is preparing to float a chain of city-centre bars with a team including celebrity chef Raymond Blanc, despite the malaise gripping leisure. Willingham, 46, has agreed a counterintuitive deal to buy London Cocktail Club through a stock market listing of her investment vehicle, Nightcap, on AIM in the coming weeks. She plans to raise £6m at a valuation of £14m. - Sunday Times



More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.